Artículos por temáticas

Restless legs syndrome is not associated with migraine with aura: a clinical study.

d'Onofrio F, Cologno D, Petretta V, Finocchi C, Autunno M, Marsala G, Usai S, Grazzi L, Omboni S, Fofi L, Barbanti P, Bussone G.

Neurol Sci. 2011 May;32 Suppl 1:S153-6. doi: 10.1007/s10072-011-0516-5.

The prevalence of restless legs syndrome in adult Saudis attending primary health care.

BaHammam A, Al-shahrani K, Al-zahrani S, Al-shammari A, Al-amri N, Sharif M.

Gen Hosp Psychiatry. 2011 Mar-Apr;33(2):102-6. doi: 10.1016/j.genhosppsych.2011.01.005. Erratum in: Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):410. Al-sharani, Khalid [corrected to Al-shahrani, Khalid]; Al-amri, Nojowd [corrected to Al-amri, Nojoud].

Restless legs syndrome in post-polio syndrome: a series of 10 patients with demographic, clinical and laboratorial findings.

Marin LF, Carvalho LB, Prado LB, Quadros AA, Oliveira AS, Prado GF.

Parkinsonism Relat Disord. 2011 Aug;17(7):563-4. doi: 10.1016/j.parkreldis.2011.02.011.

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.

Silver N, Allen RP, Senerth J, Earley CJ.

Sleep Med. 2011 May;12(5):440-4. doi: 10.1016/j.sleep.2010.11.002.

Another dopamine agonist for treatment of restless legs syndrome.

Earley CJ.

Lancet Neurol. 2011 Aug;10(8):675-7. doi: 10.1016/S1474-4422(11)70146-6. No abstract available. Erratum in: Lancet Neurol. 2011 Aug;10(8):680.

Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.

Misra UK, Kalita J, Kumar B, Prasad S.

Neurology. 2011 Jan 25;76(4):408; author reply 408-9. doi: 10.1212/WNL.0b013e3181fe7217. No abstract available.

L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children.

England SJ, Picchietti DL, Couvadelli BV, Fisher BC, Siddiqui F, Wagner ML, Hening WA, Lewin D, Winnie G, Cohen B, Walters AS.

Sleep Med. 2011 May;12(5):471-7. doi: 10.1016/j.sleep.2011.01.008.

Restless legs syndrome in pregnancy is a frequent disorder with a good prognosis.

Uglane MT, Westad S, Backe B.

Acta Obstet Gynecol Scand. 2011 Sep;90(9):1046-8. doi: 10.1111/j.1600-0412.2011.01157.x.

Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.

Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE.

Mov Disord. 2011 Sep;26(11):2065-72. doi: 10.1002/mds.23771.

A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW; XP053 Study Group..

J Clin Sleep Med. 2011 Jun 15;7(3):282-92. doi: 10.5664/JCSM.1074.

Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.

Manconi M, Ferri R, Zucconi M, Clemens S, Giarolli L, Bottasini V, Ferini-Strambi L.

Neurology. 2011 Jul 12;77(2):110-7. doi: 10.1212/WNL.0b013e3182242d91.

The relationship with iron and health outcomes in persons with restless legs syndrome.

Cuellar NG, Hanlon A, Ratcliffe SJ.

Clin Nurs Res. 2011 May;20(2):144-61. doi: 10.1177/1054773810388557.

[Treatment of secondary restless legs syndrome].

Gross N, Winkelmann J.

MMW Fortschr Med. 2011 May 26;153(21):45-8; quiz 49. German. No abstract available.

Prevalence and clinical characteristics of restless legs syndrome in chronic kidney disease patients.

Aritake-Okada S, Nakao T, Komada Y, Asaoka S, Sakuta K, Esaki S, Nomura T, Nakashima K, Matsuura M, Inoue Y.

Sleep Med. 2011 Dec;12(10):1031-3. doi: 10.1016/j.sleep.2011.06.014.

A neurophysiological approach to the complex organisation of the spine: F-wave duration and the cutaneous silent period in restless legs syndrome.

Isak B, Uluc K, Salcini C, Agan K, Tanridag T, Us O.

Clin Neurophysiol. 2011 Feb;122(2):383-90. doi: 10.1016/j.clinph.2010.07.005.